CompletedNot Applicable

Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events

Tanzania208 participantsStarted 2012-04

Plain-language summary

The purpose of this study is to understand how breast milk may protect infants from infection and promote favorable immunological, growth and development outcomes. By following mothers and their infants, we will evaluate the important interactions between infant immune responses and infectious disease events in relation to breast milk composition and feeding patterns. Our aim is to identify a set of predictive factors corresponding to healthy early infant growth and development in this setting in Northern Tanzania.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Informed consent provided by mothers, and parental consent on behalf of their infants * Confirmed maternal HIV status (HIV-1, HIV-2 or HIV-Dual seropositive or HIV-seronegative) * Stated intention to remain in the clinic catchment area ≥6 months post-partum * Singleton birth Exclusion Criteria: * None

What they're measuring

Breast milk composition

Timeframe: Up to 6 months post-partum

Trial details

NCT IDNCT01699841

SponsorCornell University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-06-15

View on ClinicalTrials.gov More HIV trials